Molecular Therapy Volume 20, (May 2012) DOI: /S (16)

Slides:

Advertisements

Similar presentations

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Advertisements

Volume 20, Issue 2, (February 2012)

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement Molecular Therapy

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro Alex C. Scibetta, Andrea B. Liebowitz,

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers Melinda Mata, Stephen.

Genome-editing Technologies for Gene and Cell Therapy

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase Molecular Therapy Volume.

Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy Molecular Therapy Volume.

Hydrodynamic Gene Delivery: Its Principles and Applications

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Evolving Gene Therapy in Primary Immunodeficiency

343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)

637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles Molecular Therapy Volume 20, (May.

Escaping the Valley of Death

John R. Martin, Christopher E. Nelson, Mukesh K

Volume 26, Issue 2, Pages (February 2018)

Volume 25, Issue 1, Pages 5-7 (January 2017)

Xiuyan Wang, Isabelle Rivière Molecular Therapy - Oncolytics

Volume 25, Issue 5, Pages (May 2017)

Jan Hoinka, Phuong Dao, Teresa M Przytycka

The Other Face of Chimeric Antigen Receptors

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

Molecular Therapy Volume 20, (May 2012) DOI: /S (16)

Volume 130, Issue 6, (September 2007)

Genome-editing Technologies for Gene and Cell Therapy

Premal Lulla, Carlos A. Ramos Molecular Therapy

Molecular Therapy Volume 7, Issue 5, (May 2003) DOI: /S (16)

547. AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs Mark A. Brimble, Junfang Zhou, Christopher.

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

611. Alpha-Dystrobrevin-3 Prevents Myopathy and Restores Diaphragm Function in the Alpha-Dystrobrevin Null Mouse Guy L. Odom, Glen B. Banks, Marvin E.

Designer Lipids Advance Systemic siRNA Delivery

Volume 25, Issue 5, Pages (May 2017)

133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy Molecular.

Erratum The American Journal of Human Genetics

660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy Geeta Shroff Molecular Therapy

Volume 143, Issue 6, (December 2010)

Volume 26, Issue 2, Pages (February 2018)

68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI) Molecular.

521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies Molecular Therapy Volume 22, Pages.

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Chae-lyul Limg, Yeon-Ju Lee, Sujeong Kim

335. High Content Analysis Platform for Optimization of Lipid Mediated CRISPR-Cas9 Delivery Strategies in Human Cells Benjamin Steyer, Jared Carlson-Stevermer,

405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement Molecular.

Volume 26, Issue 4, Pages (April 2018)

674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.

287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme Harold T.

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

Genetic enhancement of radionuclide cancer therapy

372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency Molecular.

521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS Brad E. Hoffman Molecular.

Shinya Ohkouchi, Manabu Ono, Hajime Kurosawa, Masakazu Ichinose

773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

Shigeki Yagyu, Malcolm K. Brenner

History of Oncolytic Viruses: Genesis to Genetic Engineering

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

297. Minimally Invasive Implantation of Autologous Chondrocytes Transduced with rAAV5-IGF-I Improves Longterm Cartilage Repair in Full-Thickness Chondral.

Volume 163, Issue 4, (November 2015)

Volume 163, Issue 2, (October 2015)

Volume 134, Issue 6, (September 2008)

Jingxian Feng, Jiawen Wang, Junsheng Lin, Yong Diao

Shirley Wong, Roderick A. Slavcev

In This Issue Cell Volume 145, Issue 3, (April 2011)

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

275. Time-Dependent siRNA Effects on nNOS Message in Glioma Cells in Culture Molecular Therapy Volume 20, (May 2012) DOI: 10.1016/S1525-0016(16)36079-8 Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Effects of siRNA e28_hnNOS on nNOS content at time points 4 h, 24 h, and 48 hours post-transfection. Dotted line represents the scramble negative control values. Molecular Therapy 2012 20, DOI: (10.1016/S1525-0016(16)36079-8) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions